Boston Scientific Operating Income 2010-2024 | BSX

Boston Scientific annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Boston Scientific operating income for the quarter ending March 31, 2024 was $0.673B, a 22.14% increase year-over-year.
  • Boston Scientific operating income for the twelve months ending March 31, 2024 was $2.465B, a 42.32% increase year-over-year.
  • Boston Scientific annual operating income for 2023 was $2.343B, a 42.26% increase from 2022.
  • Boston Scientific annual operating income for 2022 was $1.647B, a 37.48% increase from 2021.
  • Boston Scientific annual operating income for 2021 was $1.198B, a 1616.46% decline from 2020.
Boston Scientific Annual Operating Income
(Millions of US $)
2023 $2,343
2022 $1,647
2021 $1,198
2020 $-79
2019 $1,517
2018 $1,506
2017 $1,285
2016 $447
2015 $-283
2014 $-301
2013 $120
2012 $-3,868
2011 $904
2010 $-656
2009 $-894
Boston Scientific Quarterly Operating Income
(Millions of US $)
2024-03-31 $673
2023-12-31 $586
2023-09-30 $692
2023-06-30 $514
2023-03-31 $551
2022-12-31 $401
2022-09-30 $358
2022-06-30 $422
2022-03-31 $466
2021-12-31 $180
2021-09-30 $387
2021-06-30 $262
2021-03-31 $369
2020-12-31 $51
2020-09-30 $-206
2020-06-30 $-70
2020-03-31 $146
2019-12-31 $209
2019-09-30 $383
2019-06-30 $384
2019-03-31 $541
2018-12-31 $318
2018-09-30 $389
2018-06-30 $391
2018-03-31 $408
2017-12-31 $319
2017-09-30 $377
2017-06-30 $225
2017-03-31 $364
2016-12-31 $140
2016-09-30 $348
2016-06-30 $-334
2016-03-31 $293
2015-12-31 $-227
2015-09-30 $-299
2015-06-30 $219
2015-03-31 $24
2014-12-31 $-493
2014-09-30 $64
2014-06-30 $-69
2014-03-31 $197
2013-12-31 $127
2013-09-30 $103
2013-06-30 $220
2013-03-31 $-330
2012-12-31 $117
2012-09-30 $-594
2012-06-30 $-3,587
2012-03-31 $196
2011-12-31 $171
2011-09-30 $174
2011-06-30 $237
2011-03-31 $322
2010-12-31 $348
2010-09-30 $251
2010-06-30 $231
2010-03-31 $-1,486
2009-12-31 $-1,231
2009-09-30 $51
2009-06-30 $275
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $106.966B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.474B 24.35
Stryker (SYK) United States $128.161B 31.78
Medtronic (MDT) Ireland $106.730B 15.11
EssilorLuxottica (ESLOY) France $99.574B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.648B 0.00
Haleon (HLN) United Kingdom $38.127B 29.82
ResMed (RMD) United States $27.032B 27.03
Terumo (TRUMY) Japan $25.476B 35.98
Zimmer Biomet Holdings (ZBH) United States $24.896B 16.03
Baxter (BAX) United States $20.785B 15.16
Koninklijke Philips (PHG) Netherlands $19.474B 15.53
Insulet (PODD) United States $11.711B 61.49
Smith & Nephew SNATS (SNN) United Kingdom $10.741B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.934B 23.64
BellRing Brands (BRBR) United States $7.285B 39.17
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.379B 22.40
Perrigo (PRGO) Ireland $4.232B 12.10
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Envista Holdings (NVST) United States $3.485B 13.26
Prestige Consumer Healthcare (PBH) United States $3.482B 16.46
QuidelOrtho (QDEL) United States $2.730B 9.91
Neogen (NEOG) United States $2.679B 25.77
Green Thumb Industries (GTBIF) United States $2.630B 83.33
ICU Medical (ICUI) United States $2.357B 17.58
TG Therapeutics (TGTX) United States $2.161B 699.00
Maravai LifeSciences Holdings (MRVI) United States $1.928B 0.00
Owens & Minor (OMI) United States $1.895B 18.19
Verano Holdings (VRNOF) United States $1.790B 0.00
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
InMode (INMD) Israel $1.458B 7.55
LeMaitre Vascular (LMAT) United States $1.437B 47.43
National Vision Holdings (EYE) United States $1.388B 43.24
AdaptHealth (AHCO) United States $1.300B 9.78
Warby Parker (WRBY) United States $1.287B 0.00
AtriCure (ATRC) United States $1.115B 0.00
MacroGenics (MGNX) United States $0.982B 0.00
Canopy Growth (CGC) Canada $0.899B 0.00
BioLife Solutions (BLFS) United States $0.779B 0.00
Cresco Labs (CRLBF) United States $0.712B 0.00
VAREX IMAGING (VREX) United States $0.693B 14.98
Evolus (EOLS) United States $0.666B 0.00
Quanterix (QTRX) United States $0.613B 0.00
Jin Medical (ZJYL) China $0.547B 0.00
Valneva SE (VALN) France $0.540B 0.00
Phibro Animal Health (PAHC) United States $0.509B 11.02
PetIQ (PETQ) United States $0.487B 18.17
TerrAscend (TSNDF) Canada $0.478B 0.00
ZimVie (ZIMV) United States $0.430B 26.35
OraSure Technologies (OSUR) United States $0.421B 6.96
Biote (BTMD) United States $0.417B 3.96
Aurora Cannabis (ACB) Canada $0.393B 0.00
Surmodics (SRDX) United States $0.371B 40.11
Zynex (ZYXI) United States $0.361B 41.59
Viemed Healthcare (VMD) United States $0.314B 31.11
Cerus (CERS) United States $0.301B 0.00
Sanara MedTech (SMTI) United States $0.280B 0.00
TriSalus Life Sciences (TLSI) United States $0.274B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.70
Organigram Holdings (OGI) Canada $0.199B 0.00
Veru (VERU) United States $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.192B 0.00
Omeros (OMER) United States $0.176B 0.00
Quipt Home Medical (QIPT) United States $0.163B 0.00
High Tide (HITI) Canada $0.160B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Jushi Holdings (JUSHF) United States $0.134B 0.00
Eagleford Energy (GRUSF) United States $0.130B 65.20
FitLife Brands (FTLF) United States $0.129B 20.74
InterCure (INCR) Israel $0.122B 20.54
Fonar (FONR) United States $0.102B 8.80
Cellectar Biosciences (CLRB) United States $0.099B 0.00
MariMed (MRMD) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Allurion Technologies (ALUR) United States $0.088B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.060B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.059B 3.86
Apyx Medical (APYX) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 15.04
Bright Green (BGXX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Agape ATP (ATPC) $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 72.54
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00